SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-103380
Filing Date
2021-04-01
Accepted
2021-04-01 09:15:57
Documents
14
Period of Report
2021-03-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d140635d8k.htm   iXBRL 8-K 32469
2 EX-99.1 d140635dex991.htm EX-99.1 13699
6 GRAPHIC g140635page1.jpg GRAPHIC 3249
  Complete submission text file 0001193125-21-103380.txt   179125

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ibrx-20210329.xsd EX-101.SCH 3092
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibrx-20210329_lab.xml EX-101.LAB 17372
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibrx-20210329_pre.xml EX-101.PRE 10967
7 EXTRACTED XBRL INSTANCE DOCUMENT d140635d8k_htm.xml XML 3234
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (858) 633-0300
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

IRS No.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37507 | Film No.: 21796255
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences